In the biochemical evaluation of hirsutism, 50% or less of patients have an elevated total serum testosterone. Recent work has suggested that measuring salivary testosterone or a derived serum ‘free testosterone index’ may be of use in the evaluation of hyperandrogenism. We have measured serum total, derived serum free indices and salivary concentrations of testosterone and 5α-dihydro-testosterone in an unselected group of hirsute patients in order to assess their value in the routine evaluation of hirsutism. The assays were performed using a novel oxidation procedure to overcome the need for chromatographic separation. The ‘free testosterone index’ gave the best discrimination. Salivary androgen concentrations were comparatively poor and cannot be recommended for routine use.
References
1.
MaroulisGB. Evaluation of hirsutism and hyper-androgenaemia. Fertil Steril1981; 36: 273–305.
MathurRSMoodyLOLandgrebeS, Plasma androgens and sex hormone-binding globulin in the evaluation of hirsute females. Fertil Steril1981; 35: 29–35.
4.
WildRAUmstotESAndersenRNAndrogen parameters and their correlation with body weight in one hundred thirty-eight women thought to have hyperandrogenism. Am J Obstet Gynaecol1983; 146: 602–6.
5.
BuvatJDewaillyDMarcolinGInvestigative strategy of hyperandrogenism in women. Horm Res.1983; 18: 106–16.
6.
BrooksRV. Androgens: Physiology and pathology. In: MakinHLJ, ed. Biochemistry of Steroid Hormones2nd ed., Oxford: Blackwell Scientific Publications, 1984; 565–94.
7.
AndersonDC. The role of sex hormone binding globulin in health and disease. In: JamesVHTSerioMGiustiG, eds. The Endocrine Function of the Human Ovary. London: Academic Press, 1976; 141–58.
8.
WeistWGPaulsonJDKellerDWFree testosterone concentration in serum: a method for determination. Am J Obstet Gynaecol1978; 130: 321–8.
9.
VermeulenAStoicaTVerdonckL. The apparent free testosterone concentration, an index of androgenicity. J Clin Endocrinol Metab1971; 33: 759–67.
10.
SmithRGBeschPKDillBSaliva as a matrix for measuring free androgens: comparison with serum androgens in polycystic ovarian disease. Fertil Steril1979; 31: 513–7.
11.
BaxendalePMJacobsHSJamesVHT. Salivary testosterone: relationship to unbound plasma testosterone in normal and hyperandrogenic women. Clin Endocrinol1982; 16: 595–603.
12.
ViningRFMcGinleyRSymonsRG. Hormones in saliva: mode of entry and consequent implications for clinical interpretation. Clin Chem.1983; 29: 1752–6.
13.
PuriVPuriCPKumarTC Anand. Serum levels of dihydrotestosterone in male rhesus monkeys estimated by a non-chromatographic radioimmunoassay method. J Steroid BioChem.1981; 14: 877–81.
14.
HunterWMNarsPWRutherfordFJ. Preparation and behaviour of (125I) labelled radioligands for phenolic and neutral steroids. In: CameronEHDWalkerSGGriffithsK, eds. Fifth Tenovus Workshop: Steroidimmunoassay. Cardiff: Alpha Omega Publishing, 1974; 141–52.
15.
DesbuquoisBAurbachGD. Use of polyethylene glycol to separate free and antibody bound peptide hormones in radioimmunoassay. J Clin Endocrinol Metab1971; 33: 732–8.
16.
CannellGRMortimerRHThomasMJ. Comparison of DHT-binding and monoclonal immunoradiometric methods for the measurement of sex hormone-binding globulin. Clin Chim Acta1985; 146: 195–201.
17.
AulettaFJCaldwellBVHamiltonGL. Androgens: testosterone and dihydrotestosterone. In: JaffeBMBehrmanHR, eds. Methods of Hormone Radioimmunoassay. London: Academic Press, 1974; 359–70.
18.
WakelinKIsmailAAAGoldieDJ. Relationship of 5β-dihydrotestosterone and 5α-dihydrotestosterone to testosterone in health and disease. J Endocrinol1980; 87: 45P–46P.
19.
Riad-FahmyDReadGFWalkerRFSteroids in saliva for assessing endocrine function. Endocrine Rev1982; 3: 367–95.
20.
Kahn-DawoodFSChoeJKDawoodMY. Salivary and plasma bound and ‘free’ testosterone in men and women. Am J Obstet Gynaecol1984; 148: 441–5.
21.
BaxendalePMJacobsHSJamesVHT. Plasma and salivary androstenedione and dihydrotestosterone in women with hyperandrogenisn. Clin Endocrinol1983; 18: 447–57.
22.
IsmailAAAAstleyPCawoodMTestosterone assays: Guidelines for the provision of a clinical biochemistry service. Ann Clin BioChem.1986; 23: 135–45.
23.
BaxendalePMJamesVHT. Specificity of androgen measurements in saliva. In: ReadGFRiad-FahmyDWalkerRFGriffithsK eds. Ninth Tenovus Workshop: Immunoassays of Steroids in Saliva. Cardiff: Alpha Omega Publishing, 1984; 228–38.
24.
JamesVHTBaxendalePM. Androgens in saliva. In: ReadGFRiad-FahmyDWalkerRFGriffithsK, eds. Ninth Tenovus Workshop: Immunoassays of Steroids in Saliva. Cardiff: Alpha Omega Publishing, 1984; 193–201.
25.
CarterGDHollandSMAlaghband-ZadehJInvestigation of hirsutism: testosterone is not enough. Ann Clin BioChem.1983; 20: 262–3.
26.
NanjeeMNWheelerMJ. Plasma free testosterone—is an index sufficient?Ann Clin BioChem.1985; 22: 387–90.
27.
GiacominiMWrightF. The effects of progesterone and pregnanedione on the reductive metabolism of dihydrotestosterone in human skin. J Steroid BioChem.1980; 13: 645–51.
28.
IsmailAAAAstleyPBurrWAThe role of testosterone measurement in the investigation of androgen disorders. Ann Clin BioChem.1986; 23: 113–34.
29.
SnedecorGW. Queries. Biometrics1952; 8: 85–6.
30.
BancroftJDavidsonDWWarnerPAndrogens and sexual behaviour in women using oral contraceptives. Clin Endocrinol1980; 12: 327–40.
